Trial Outcomes & Findings for Incisional Negative Pressure Wound Therapy (NCT NCT01759381)

NCT ID: NCT01759381

Last Updated: 2015-07-02

Results Overview

The patient will be assessed for signs/symptoms of infection within the 3 month post-operative period.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

19 participants

Primary outcome timeframe

3 months

Results posted on

2015-07-02

Participant Flow

Participant milestones

Participant milestones
Measure
No Negative Pressure Wound Therapy Device
This control group will not receive the negative pressure wound therapy device. Post operative dressings will be per the surgeon's standard routine.
NPWT Arm Therapy
This group will receive NPWT as opposed to the standard incisional dressing following complex spinal surgery. Negative pressure wound therapy (NPWT)
Overall Study
STARTED
8
11
Overall Study
COMPLETED
7
11
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
No Negative Pressure Wound Therapy Device
This control group will not receive the negative pressure wound therapy device. Post operative dressings will be per the surgeon's standard routine.
NPWT Arm Therapy
This group will receive NPWT as opposed to the standard incisional dressing following complex spinal surgery. Negative pressure wound therapy (NPWT)
Overall Study
Death
1
0

Baseline Characteristics

Incisional Negative Pressure Wound Therapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
No Negative Pressure Wound Therapy Device
n=8 Participants
This control group will not receive the negative pressure wound therapy device. Post operative dressings will be per the surgeon's standard routine.
NPWT Arm Therapy
n=11 Participants
This group will receive NPWT as opposed to the standard incisional dressing following complex spinal surgery. Negative pressure wound therapy (NPWT)
Total
n=19 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
n=39 Participants
9 Participants
n=41 Participants
13 Participants
n=35 Participants
Age, Categorical
>=65 years
4 Participants
n=39 Participants
2 Participants
n=41 Participants
6 Participants
n=35 Participants
Sex: Female, Male
Female
7 Participants
n=39 Participants
7 Participants
n=41 Participants
14 Participants
n=35 Participants
Sex: Female, Male
Male
1 Participants
n=39 Participants
4 Participants
n=41 Participants
5 Participants
n=35 Participants
Region of Enrollment
United States
8 participants
n=39 Participants
11 participants
n=41 Participants
19 participants
n=35 Participants

PRIMARY outcome

Timeframe: 3 months

The patient will be assessed for signs/symptoms of infection within the 3 month post-operative period.

Outcome measures

Outcome measures
Measure
No Negative Pressure Wound Therapy Device
n=7 Participants
This control group will not receive the negative pressure wound therapy device. Post operative dressings will be per the surgeon's standard routine.
NPWT Arm Therapy
n=11 Participants
This group will receive NPWT as opposed to the standard incisional dressing following complex spinal surgery. Negative pressure wound therapy (NPWT)
Number of Participants With Post-operative Infection (NPWT)
1 participants
2 participants

Adverse Events

No Negative Pressure Wound Therapy Device

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

NPWT Arm Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
No Negative Pressure Wound Therapy Device
n=8 participants at risk
This control group will not receive the negative pressure wound therapy device. Post operative dressings will be per the surgeon's standard routine.
NPWT Arm Therapy
n=11 participants at risk
This group will receive NPWT as opposed to the standard incisional dressing following complex spinal surgery. Negative pressure wound therapy (NPWT)
Nervous system disorders
Death
12.5%
1/8 • Number of events 1 • pre-op - 3 months
0.00%
0/11 • pre-op - 3 months

Other adverse events

Adverse event data not reported

Additional Information

Carlos A. Bagley

Duke

Phone: 919-943-1564

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place